-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Yesterday evening, the World Health Organization (WHO) approved the Sinovac vaccine developed by the Chinese company Kexing Pharmaceutical to be added to the emergency use list, making it the seventh new crown vaccine to be certified by WHO for safety, effectiveness and quality.
It is reported that the WHO independent expert team said in a statement that it is recommended that Kexing's vaccine be used for adults over 18 years of age, and a second injection should be given 2-4 weeks later.
This is the second domestic vaccine that has been urgently approved by the WHO.